摘要
目的探讨尿道低温双极等离子电切(plasmakinetic resection of prostate,PKRP)治疗前列腺增生症(benignprostatic hyperplasia,BPH)的有效性及安全性.方法采用经尿道低温双极等离子前列腺电切术治疗BPH 45例;随访3~10个月.结果前列腺质量28~105 g,平均(47±16)g,手术时间15~120 min,平均手术时间(50±12)min,无1例需要输血,无电切综合征发生,术后平均留置尿管4 d,术后平均住院时间7 d.最大尿流率(Qmax)由术前的(7.3±1.5)ml/s上升至术后3个月的(16.2±4.4)ml/s(P<0.01),前列腺症状评分(IPSS),术前为(27.6±1.3)分,术后3个月降至(5.8±1.0)分(P<0.01).结论经尿道低温双极等离子前列腺电切术疗效好,并发症少,手术安全.
Objective To assess the efficacy and safety of transurethral bipolar plasmakinetic resection of benign prostatic hyperplasia (BPH). Methods A total of 45 cases of BPH were treated by transurethral bipolar plasmakinetic resection of prostate (PKRP) and were followed up for 3-10 months.Results The weight of the resected prostate was 28-105 g with an average of (47±16) g, the operation time was 15-120 min with an average of (50±12) min. No case needed blood transfusion during the operation and no transurethral resection syndrome occurred. The mean catheterization time was 4 d and the mean postoperative hospital stay was 7 d. Peak urine flow increased from (7.3±1.5) ml/s to (16.2±4. 4) ml/s and IPSS decreased from (27.6±1.3) to (5.8±1.0) in 3 months postoperatively. Conclusion Transurethral bipolar plasmakinetic resection of prostate is effective and safe with less complications.
出处
《第三军医大学学报》
CAS
CSCD
北大核心
2005年第14期1519-1520,共2页
Journal of Third Military Medical University
关键词
双极等离子
前列腺增生症
经尿道前列腺切除术
bipolar plasmakinetic
benign prostatic hyperplasia
transurethral resection